EPA Speaks on PFAS: What Manufacturers Need to Know

April 30, 2025

Reading Time : 1 min

By: David H. Quigley, Shivani Swami

After addressing a number of other programs over the first 100 days of the new administration, on April 28, 2025, the Environmental Protection Agency (EPA) finally addressed PFAS. Administrator Lee Zeldin outlined a number of actions—old and new—aimed at manufacturers and importers of PFAS and PFAS-containing products with an emphasis on “sound science” and the need for more robust data on PFAS toxicity.

The announcement foreshadows a more risk-based review of PFAS by EPA, signaling that the Agency may be receptive to industry submissions regarding variances in toxicological profiles of different PFAS and open to regulating PFAS commensurate with their toxicity and the risk they present to human health and environment. EPA committed to rolling out a comprehensive PFAS Testing Strategy, which could include new data development and information-gathering obligations for companies dealing in PFAS-containing products. EPA will include several PFAS chemicals on the Toxic Release Inventory, triggering reporting obligations for manufacturers, processors and users of PFAS. The Agency also reaffirmed its commitment to enforcing the TSCA Reporting Rule, extinguishing lingering rumors of the rule’s demise, although the Agency hinted at possible accommodations for small businesses and article importers.

Follow this space for updates on comment periods, reporting deadlines and emerging rules and guidance, as Zeldin indicated in his announcement that “this list is the first, not the last, of all decisions and actions EPA will be taking to address PFAS.”

Share This Insight

Previous Entries

PFAS Press

November 11, 2025

On November 10, 2025, the U.S. Environmental Protection Agency (EPA) released the pre-publication draft proposed rule to amend the PFAS reporting requirements under TSCA, entitled “Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) Data Reporting and Recordkeeping Under the Toxic Substances Control Act (TSCA); Revision to Regulation.” The proposal aims to augment the exemptions to the scope of the reporting requirements and introduces additional modifications to make the rule “more practical and implementable and reduce unnecessary, or potentially duplicative, reporting requirements for businesses.” Potentially offering even greater flexibility, it concludes with a request for comment on additional provisions. 

...

Read More

PFAS Press

September 16, 2025

On September 4, the U.S. Environmental Protection Agency (EPA) (finally) published its Spring 2025 Unified Agenda of Regulatory and Deregulatory Actions (UA), a semiannual publication outlining federal agencies’ regulatory priorities and timelines for the upcoming year. The UA included a notice of its intent to rescind drinking water limits set by a Biden-era rule for three per- and polyfluoroalkyl (PFAS) substances and one PFAS mixture. EPA also published a notice of intent to retain limits on PFOA and PFOS, although with extended timelines for compliance.

...

Read More

PFAS Press

September 5,2025

On August 20, 2025, Denmark, Germany, the Netherlands, Norway and Sweden submitted an update to the proposal to restrict PFAS under the European Union’s REACH regulation that they originally submitted in January 2023. The revision reflects their comprehensive evaluation of more than 5,000 scientific and technical comments submitted by stakeholders, including industry representatives, researchers and civil society organizations.

...

Read More

PFAS Press

August 6, 2025

On August 6, 2025, the U.S. Food and Drug Administration (FDA) became the latest governmental agency to confirm that fluoropolymers are both safe and necessary. After an independent safety review of fluoropolymers in medical devices showed no conclusive evidence of health issues, FDA concluded that fluoropolymers are “very unlikely to cause toxicity” because of molecular size and further that they are essential for medical devices to function. As a result, “FDA’s evaluation is that currently there is no reason to restrict their continued use in devices.”

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.